Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer

por Dunne, Philip D., Coleman, Helen G., Bankhead, Peter, Alderdice, Matthew, Gray, Ronan T., McQuaid, Stephen, Bingham, Victoria, Loughrey, Maurice B., James, Jacqueline A., McCorry, Amy M.B., Gilmore, Alan, Holohan, Caitriona, Klingbiel, Dirk, Tejpar, Sabine, Johnston, Patrick G., McArt, Darragh G., Nicolantonio, Federica Di, Longley, Daniel B., Lawler, Mark
Publicado 2018